ctDNA Predicts Pain Response in a Multi-Institutional Phase II Trial of Palliative Radiation, Palbociclib and Hormone Therapy in Metastatic Breast Cancer

被引：0
|
作者：
Torres, M. [1 ]
Friend, S. [2 ]
Niemierko, A. [3 ]
Lin, J. Y. [1 ]
Iafrate, A. [3 ]
Xiao, C. [4 ]
Kahn, S. T. [5 ]
Godette, K. D. [6 ]
Hanasoge, S. [5 ]
Yu, D. S. [6 ]
Eng, T. Y. [5 ]
Cheney, M. D. [7 ]
Wiggers, N. [8 ]
Pippas, A. [9 ]
Goginini, K.
Meisel, J. [10 ]
Schuster, D. M. [11 ]
Bardia, A. [12 ]
Miller, A. H. [13 ]
Felger, J.
Switchenko, J. [14 ]
Zelnak, A. [15 ]
Kalinsky, K. [16 ]
Daniels, T. [2 ]
Medford, A. [3 ]
Bhave, M. [17 ]
机构：
[1] Emory Univ, Glenn Family Breast Ctr, Winship Canc Inst, Atlanta, GA USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
[4] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA USA
[5] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA USA
[6] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA USA
[7] Spectrum Healthcare Partners, Portland, ME USA
[8] Northside Hosp, Atlanta, GA USA
[9] Piedmont Columbus Reg, John B. Amos Canc Ctr, Columbus, GA USA
[10] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA USA
[11] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA USA
[12] UCLA, Los Angeles, CA USA
[13] Emory Univ, Sch Medi, Dept Psychiat & Behav Sci, Atlanta, GA USA
[14] Emory Univ, Atlanta, GA USA
[15] Northside Hosp, Atlanta Canc Care, Atlanta, GA USA
[16] Emory Winship Canc Inst, Atlanta, GA USA
[17] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1037
引用
收藏
页码：S164 / S164
页数：1
相关论文
共 50 条
  • [41] An unusual durable response with palbociclib plus letrozole in hormone receptor positive metastatic breast cancer after multiple lines of therapy
    Vanidassane, Ilavarasi
    Dhamija, Ekta
    Naik, Shailendra Singh
    Batra, Atul
    INDIAN JOURNAL OF CANCER, 2020, 57 (03) : 348 - 350
  • [42] Evaluation of the HER2 and Hormone Receptor Status in Metastatic Breast Cancer Using Cell Blocks: A Multi-Institutional Study
    Nishimura, Rieko
    Murata, Yuya
    Mori, Kiyoshi
    Yamashiro, Katsushige
    Kuraoka, Kazuya
    Ichihara, Shu
    Taguchi, Kenichi
    Suzuki, Hiroyoshi
    Ito, Masahiro
    Yamashita, Natsumi
    ACTA CYTOLOGICA, 2018, 62 (04) : 288 - 294
  • [43] Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
    Ina Mathilde Kjær
    Søren Kahns
    Signe Timm
    Rikke Fredslund Andersen
    Jonna Skov Madsen
    Erik Hugger Jakobsen
    Tomasz Piotr Tabor
    Anders Jakobsen
    Troels Bechmann
    Scientific Reports, 13
  • [44] Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
    Kjaer, Ina Mathilde
    Kahns, Soren
    Timm, Signe
    Andersen, Rikke Fredslund
    Madsen, Jonna Skov
    Jakobsen, Erik Hugger
    Tabor, Tomasz Piotr
    Jakobsen, Anders
    Bechmann, Troels
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] A multi-institutional phase I/II trial of dose-per-fraction escalation for localized prostate cancer
    Ritter, MA
    Chappell, RJ
    Tome, WA
    Kupelian, PA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S124 - S124
  • [46] Dose-per-fraction escalation for localized prostate cancer - A multi-institutional phase I/II trial
    Ritter, M. A.
    Forman, J. D.
    Petereit, D. G.
    Kupelian, P. A.
    Wang, D.
    Walker, W.
    Fowler, J. F.
    Chappell, R. J.
    TAme, W. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S11 - S11
  • [47] TWO-WEEK COURSE OF PREOPERATIVE CHEMORADIOTHERAPY FOR RECTAL CANCER: A PHASE II MULTI-INSTITUTIONAL CLINICAL TRIAL
    Lee, J. H.
    Kim, D. Y.
    Park, H. C.
    Chie, E. K.
    Jang, H. S.
    ANNALS OF ONCOLOGY, 2013, 24
  • [48] Short Course, Two Day Accelerated Hypofractionated Partial Breast Balloon Brachytherapy: A Phase II Multi-Institutional Trial
    Kahn, J.
    Gupta, A.
    Mukhopadhyay, N. D.
    Khan, A. J.
    Haffty, B. G., Jr.
    Brown, S. E., Jr.
    Chen, P. Y.
    Cuttino, L. W.
    Vicini, F. A.
    Arthur, D. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E576 - E577
  • [49] Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring
    Crivellari, D
    Lombardi, D
    Corona, G
    Massacesi, C
    Talamini, R
    Sorio, R
    Magri, MD
    Lestuzzi, C
    Lucenti, A
    Veronesi, A
    Toffoli, G
    ANNALS OF ONCOLOGY, 2006, 17 (05) : 807 - 812
  • [50] Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR) plus metastatic breast cancer (MBC)
    Gucalp, Ayca
    Edelweiss, Marcia
    Patil, Sujata
    Gounder, Mrinal M.
    Feigin, Kimberly N.
    Corben, Adriana
    Arumov, Artavazd
    Traina, Tiffany A.
    CANCER RESEARCH, 2018, 78 (04)
12345